Results 161 to 170 of about 4,665 (204)

Can bacteria control the human brain? [PDF]

open access: yesCommun Integr Biol
Berdichevskiy GM   +3 more
europepmc   +1 more source

Non-Motor Symptoms: The Hidden Face of Parkinson's Disease. [PDF]

open access: yesCells
Cattaneo C   +5 more
europepmc   +1 more source

Spaceflight exposome/microgravity effects on the psychoimmunoneuroendocrine system. [PDF]

open access: yesNPJ Microgravity
Capri M   +5 more
europepmc   +1 more source

Modifiers in Effects of Combined Pharmacotherapy and Psychotherapy versus Pharmacotherapy Alone for Adult Depression: An Individual Participant Data Meta-Analysis.

open access: yesPsychother Psychosom
Ciharova M   +49 more
europepmc   +1 more source

[Serotonin].

open access: yesPostepy biochemii, 1966
R W, Schramm, H, Schrammowa
openaire   +1 more source

Animal Models for the Study of Neurological Diseases and Their Link to Sleep. [PDF]

open access: yesBiomedicines
Rubio C   +5 more
europepmc   +1 more source

Serotonin

Current Biology, 2023
Serotonin, also known as 5-hydroxytryptamine or 5-HT, is a neuromodulator widely recognized for its role in various psychoactive drugs. These drugs can exhibit antidepressant, antipsychotic, anxiolytic, empathogenic, or psychedelic effects, depending on their specific interactions with the serotonin system as well as other neuromodulators such as ...
Ligneul, Romain, Mainen, Zachary
openaire   +4 more sources

Serotonin syndrome

Drug and Therapeutics Bulletin, 2022
The serotonin syndrome is a life-threatening adverse drug reaction resulting from excess serotonergic agonism due to interactions between multiple drugs, poisoning, or less commonly due to therapeutic action of a single drug. The central triad of features in serotonin syndrome are altered mental state, autonomic hyperactivity, and neuromuscular ...
Stuart Maitland, Mark Baker
openaire   +2 more sources

SEROTONIN SYNDROME

Critical Care Clinics, 1997
Serotonin syndrome is a potentially life-threatening complication of psychopharmacologic drug therapy. The syndrome is produced most often by the concurrent use of two or more drugs that increase brainstem serotonin activity and is often unrecognized because of the varied and nonspecific nature of its symptomatology. Serotonin syndrome is characterized
Ivanuša, Zrinka   +2 more
openaire   +5 more sources

Home - About - Disclaimer - Privacy